Asia-Pacific Blood Transfusion Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Instruments & Kits and Reagents), Application (Blood Grouping and Disease Screening), and End User (Hospitals, Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies)

The APAC blood transfusion diagnostics market is expected to grow from US$ 875.20 million in 2022 to US$ 1,380.34 million by 2028. It is estimated to grow at a CAGR of 7.9% from 2022 to 2028.

Elevated Healthcare Expenditure in Emerging Economies to Boost Market in Coming Years

Healthcare budget allocations help countries strengthen workforces and improve this sector's productivity, thereby contributing to economic performance. Rapid economic developments allow developing countries to raise their healthcare expenditures, enabling them to establish better medical service infrastructure by leveraging technological advancements. The Government of India, through its National Health Authority agency, implemented Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) in 2019. This scheme has facilitated free/affordable treatment for cancer patients in the country. As per the data published by the National Health Authority of India, ~470,133 cancer cases were treated under AB-PMJAY in 2019. Such initiatives are likely to provide lucrative opportunities for companies in the blood transfusion diagnostics market to introduce advanced technologies for the blood transfusion diagnostics market in Asia Pacific.

Market Overview

China dominated the blood transfusion diagnostics market in Asia Pacific in 2022. The market growth in China is attributed to the increased use of advanced technologies in blood-related diagnoses, followed by a surge in the number of blood donation camps and blood banks in the country. The nation has a blood donation law in place that allows voluntary unpaid blood donation, and the donated blood can only be used for clinical practice. China's National Health Commission recorded 15.53 million blood donations in 2020, despite the pandemic-related restrictions. This figure is 40-times more than that recorded in 1998. According to Xinhua news, from January to April 2021, 5.12 million blood donations were registered nationwide. Therefore, the increasing number of blood donations for clinical use leads to high demand for blood transfusion diagnostics to screen the blood groups.

APAC Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

APAC Blood Transfusion Diagnostics Market Segmentation

The APAC blood transfusion diagnostics market is segmented based on product, application, end user, and country.

Based on product, the APAC blood transfusion diagnostics market is bifurcated into instruments & kits and reagents. The instruments & kits segment held the larger market share in 2022.
Based on application, the APAC blood transfusion diagnostics market is bifurcated into blood grouping and disease screening. The disease screening segment held the larger market share in 2022.
Based on end user, the APAC blood transfusion diagnostics market is segmented into hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies. The blood banks segment dominated the market in 2022.
Based on country, the APAC blood transfusion diagnostics market has been categorized into China, India, Japan, South Korea, Australia, and Rest of APAC. Our regional analysis states that China dominated the market in 2022.

Abbott; BAG Diagnostics GmbH; Bio-Rad Laboratories, Inc.; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; Grifols, S.A.; Immucor, Inc.; Ortho Clinical Diagnostics (QuidelOrtho Corporation); Quotient Limited; and Thermo Fisher Scientific Inc. are the leading companies operating in the APAC blood transfusion diagnostics market.

1. Introduction 17

1.1 Scope of the Study. 17

1.2 The Insight Partners Research Report Guidance. 18

1.3 Market Segmentation. 19

1.3.1 APAC Blood Transfusion Diagnostics Market – By Product 21

1.3.2 APAC Blood Transfusion Diagnostics Market – By Application. 21

1.3.3 APAC Blood Transfusion Diagnostics Market – By End User 21

1.3.4 APAC Blood Transfusion Diagnostics Market – By Country. 21

2. Key Takeaways 22

3. Research Methodology 25

3.1 Coverage. 27

3.2 Secondary Research. 27

3.3 Primary Research. 28

4. APAC Blood Transfusion Diagnostics Market – Market Landscape 29

4.1 Overview.. 29

4.2 APAC PEST Analysis. 30

4.3 Experts Opinion. 31

5. APAC Blood Transfusion Diagnostics Market – Key Market Dynamics 32

5.1 Market Drivers. 32

5.1.1 Rapid Increase in Chronic Diseases. 32

5.1.2 Need for Blood Transfusion due to Rise in Organ Transplants Surgeries. 32

5.2 Market Restraints. 33

5.2.1 Problems Associated with Blood Transfusion Services. 33

5.3 Market Opportunities. 34

5.3.1 Elevated Healthcare Expenditure in Emerging Economies. 34

5.4 Future Trends. 34

5.4.1 Technological Developments in Blood Transfusion Diagnostics. 34

5.5 Impact Analysis. 35

6. Blood Transfusion Diagnostics Market– APAC Analysis 36

6.1 APAC Blood Transfusion Diagnostics Market Revenue Forecast and Analysis. 36

7. APAC Blood Transfusion Diagnostics Market Analysis – By Product 38

7.1 Overview.. 38

7.2 APAC Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028) 38

7.3 Instruments and Kits. 39

7.3.1 Overview.. 39

7.3.2 Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million) 39

7.4 Reagents. 41

7.4.1 Overview.. 41

7.4.2 Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million) 41

8. APAC Blood Transfusion Diagnostics Market Analysis – By Application 43

8.1 Overview.. 43

8.2 APAC Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028) 43

8.3 Disease Screening. 44

8.3.1 Overview.. 44

8.3.2 Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million) 44

8.4 Blood Grouping. 46

8.4.1 Overview.. 46

8.4.2 Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million) 46

9. APAC Blood Transfusion Diagnostics Market Analysis – By End User 48

9.1 Overview.. 48

9.2 APAC Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028, (%) 48

9.3 Blood Banks. 49

9.3.1 Overview.. 49

9.3.2 Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million) 49

9.4 Hospitals. 51

9.4.1 Overview.. 51

9.4.2 Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million) 51

9.5 Diagnostic Laboratories. 52

9.5.1 Overview.. 52

9.5.2 Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million) 52

9.6 Plasma Fractionation Companies. 53

9.6.1 Overview.. 53

9.6.2 Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million) 53

10. APAC Blood Transfusion Diagnostics Market Analysis – Country Analysis 55

10.1 Overview.. 55

10.1.2 APAC: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%) 57

10.1.2.1 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 58

10.1.2.1.1 Overview.. 58

10.1.2.1.2 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 59

10.1.2.1.3 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million) 60

10.1.2.1.4 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million) 60

10.1.2.1.5 China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million) 61

10.1.2.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 62

10.1.2.2.1 Overview.. 62

10.1.2.2.2 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 63

10.1.2.2.3 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million) 64

10.1.2.2.4 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million) 64

10.1.2.2.5 Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million) 65

10.1.2.3 India Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 66

10.1.2.3.1 Overview.. 66

10.1.2.3.2 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 68

10.1.2.3.3 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million) 69

10.1.2.3.4 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million) 69

10.1.2.3.5 India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million) 70

10.1.2.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 71

10.1.2.4.1 Overview.. 71

10.1.2.4.2 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 71

10.1.2.4.3 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million) 72

10.1.2.4.4 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million) 73

10.1.2.4.5 South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million) 73

10.1.2.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 74

10.1.2.5.1 Overview.. 74

10.1.2.5.2 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 74

10.1.2.5.3 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million) 75

10.1.2.5.4 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million) 76

10.1.2.5.5 Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million) 76

10.1.2.6 Rest of APAC: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million) 78

10.1.2.6.1 Overview.. 78

10.1.2.6.2 Rest of APAC: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million) 78

10.1.2.6.3 Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million) 79

10.1.2.6.4 Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million) 80

10.1.2.6.5 Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million) 80

11. Industry Landscape 81

11.1 Overview.. 81

11.2 Inorganic Growth Strategies. 81

11.2.1 Overview.. 81

11.3 Organic Growth Strategies. 83

11.3.1 Overview.. 83

12. Company Profiles 85

12.1 Grifols, S.A. 85

12.1.1 Key Facts. 85

12.1.2 Business Description. 85

12.1.3 Products and Services. 86

12.1.4 Financial Overview.. 87

12.1.5 SWOT Analysis. 90

12.1.6 Key Developments. 91

12.2 F. Hoffmann-La Roche Ltd. 92

12.2.1 Key Facts. 92

12.2.2 Business Description. 92

12.2.3 Products and Services. 93

12.2.4 Financial Overview.. 94

12.2.5 SWOT Analysis. 96

12.2.6 Key Developments. 97

12.3 Immucor, Inc. 98

12.3.1 Key Facts. 98

12.3.2 Business Description. 98

12.3.3 Products and Services. 99

12.3.4 Financial Overview.. 99

12.3.5 SWOT Analysis. 100

12.3.6 Key Developments. 101

12.4 Bio-Rad Laboratories, Inc. 102

12.4.1 Key Facts. 102

12.4.2 Business Description. 102

12.4.3 Products and Services. 103

12.4.4 Financial Overview.. 104

12.4.5 SWOT Analysis. 106

12.4.6 Key Developments. 107

12.5 Abbott 108

12.5.1 Key Facts. 108

12.5.2 Business Description. 108

12.5.3 Products and Services. 109

12.5.4 Financial Overview.. 109

12.5.5 SWOT Analysis. 112

12.5.6 Key Developments. 113

12.6 Thermo Fisher Scientific Inc. 114

12.6.1 Key Facts. 114

12.6.2 Business Description. 114

12.6.3 Products and Services. 115

12.6.4 Financial Overview.. 115

12.6.5 SWOT Analysis. 118

12.6.6 Key Developments. 118

12.7 Ortho Clinical Diagnostics (QuidelOrtho Corporation) 119

12.7.1 Key Facts. 119

12.7.2 Business Description. 119

12.7.3 Products and Services. 120

12.7.4 Financial Overview.. 120

12.7.5 SWOT Analysis. 121

12.7.6 Key Developments. 122

12.8 DiaSorin S.p.A. 123

12.8.1 Key Facts. 123

12.8.2 Business Description. 123

12.8.3 Products and Services. 124

12.8.4 Financial Overview.. 125

12.8.5 SWOT Analysis. 128

12.8.6 Key Developments. 129

12.9 Quotient Limited. 130

12.9.1 Key Facts. 130

12.9.2 Business Description. 130

12.9.3 Products and Services. 131

12.9.4 Financial Overview.. 131

12.9.5 SWOT Analysis. 133

12.9.6 Key Developments. 134

12.10 BAG Diagnostics GmbH.. 135

12.10.1 Key Facts. 135

12.10.2 Business Description. 135

12.10.3 Products and Services. 136

12.10.4 Financial Overview.. 136

12.10.5 SWOT Analysis. 137

12.10.6 Key Developments. 137

13. Appendix 138

13.1 About The Insight Partners. 138

13.2 Glossary of Terms. 139

LIST OF TABLES

Table 1. APAC Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Mn) 37

Table 2. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million) 60

Table 3. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million) 60

Table 4. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million) 61

Table 5. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million) 64

Table 6. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million) 64

Table 7. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million) 65

Table 8. India: National Estimation of Blood Requirement in India (2018) 67

Table 9. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million) 69

Table 10. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million) 69

Table 11. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million) 70

Table 12. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million) 72

Table 13. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million) 73

Table 14. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million) 73

Table 15. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million) 75

Table 16. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million) 76

Table 17. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million) 76

Table 18. Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million) 79

Table 19. Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By Application (US$ Million) 80

Table 20. Rest of APAC: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million) 80

Table 21. Recent Inorganic Growth Strategies. 81

Table 22. Recent Organic Growth Strategies. 83

Table 23. Glossary of Terms. 139

LIST OF FIGURES

Figure 1. APAC Blood Transfusion Diagnostics Market Segmentation. 19

Figure 2. APAC Blood Transfusion Diagnostics Market – By Country. 20

Figure 3. APAC Blood Transfusion Diagnostics Market Overview.. 22

Figure 4. APAC Blood Transfusion Diagnostics Market, By Product 23

Figure 5. APAC Blood Transfusion Diagnostics Market, By Country. 24

Figure 6. APAC: PEST Analysis. 30

Figure 7. Experts Opinion. 31

Figure 8. Impact Analysis: APAC Blood Transfusion Diagnostics Market 35

Figure 9. APAC Blood Transfusion Diagnostics Market– Revenue Forecast and Analysis. 36

Figure 10. APAC Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028) 38

Figure 11. APAC Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million) 40

Figure 12. APAC Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million) 42

Figure 13. APAC Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028) 43

Figure 14. APAC Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million) 45

Figure 15. APAC Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million) 47

Figure 16. APAC Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028 (%) 48

Figure 17. APAC Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million) 50

Figure 18. APAC Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million) 51

Figure 19. APAC Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million) 52

Figure 20. APAC Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million) 54

Figure 21. APAC Blood Transfusion Diagnostics Market Overview, by Country (2021) 56

Figure 22. APAC: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%) 57

Figure 23. China: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 59

Figure 24. Japan: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 63

Figure 25. India: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 68

Figure 26. South Korea: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 72

Figure 27. Australia: Blood Transfusion Diagnostics Market Revenue and Forecasts to 2028 (US$ Million) 75

Figure 28. Rest of APAC: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Million) 79

Abbott
BAG Diagnostics GmbH
Bio-Rad Laboratories, Inc.
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd
Grifols, S.A.
Immucor, Inc.
Ortho Clinical Diagnostics (QuidelOrtho Corporation)
Quotient Limited
Thermo Fisher Scientific Inc.

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC blood transfusion diagnostics market.
Highlights key business priorities to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC blood transfusion diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the blood transfusion diagnostics market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000

$4000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

The APAC blood transfusion diagnostics market is expected to grow from US$ 875.20 million in 2022 to US$ 1,380.34 million by 2028. It is estimated to grow at a CAGR of 7.9% from 2022 to 2028.

APAC Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample